Denali Therapeutics Inc

DNLI

Equity

ISIN null / Valor 39149539

NASDAQ (2026-02-20)

USD 20.19-0.25%

Denali Therapeutics Inc
UMushroom community rating:

3.00 1 votes No rating yet

NegativeNeutralPositive

About company

Denali Therapeutics Inc is a biotechnology company focused on developing therapies for neurodegenerative and lysosomal storage diseases. Leveraging their expertise in the biology of these conditions, the company's core portfolio includes programs in various stages of clinical and preclinical development aimed at addressing the underlying causes of these diseases. With a commitment to rigorous therapeutic discovery and development, Denali is dedicated to advancing molecular therapeutics that have the potential to significantly improve the lives of patients facing these challenging medical conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-6.48%1Y

-33.8%3Y

-69.1%5Y

Performance

61.6%1Y

61.1%3Y

62.5%5Y

Volatility

2961 M

Market cap (USD)

1,798,754

Daily traded volume (Shares)

20.49 / 19.93

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.00

1 votes

Performance:

3.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

John Noyb

Switzerland, 25 Jun 2025

EQUITIES OF THE SAME SECTOR

Viking Therapeutics Inc

Viking Therapeutics Inc Valor: 24839858

Annual Return

-50%0%+50%

Risk level

110

-0.23%USD 31.03

CureVac N.V.

CureVac N.V. Valor: 56537572

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 4.66

Nano-X Imaging Ltd.

Nano-X Imaging Ltd. Valor: 56410599

Annual Return

-50%0%+50%

Risk level

110

1.67%USD 2.43

ALX Oncology Holdings Inc

ALX Oncology Holdings Inc Valor: 55754366

Annual Return

-50%0%+50%

Risk level

110

-5.77%USD 2.45

ACELYRIN INC

ACELYRIN INC Valor: 126441937

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 2.27

Stride Inc

Stride Inc Valor: 58406765

Annual Return

-50%0%+50%

Risk level

110

-0.43%USD 82.58

Biohaven Research Ltd

Biohaven Research Ltd Valor: 121902526

Annual Return

-50%0%+50%

Risk level

110

-1.40%USD 11.23

Cooper Companies Inc

Cooper Companies Inc Valor: 132951296

Annual Return

-50%0%+50%

Risk level

110

0.47%USD 84.07

Amneal Pharmaceuticals Inc

Amneal Pharmaceuticals Inc Valor: 41368351

Annual Return

-50%0%+50%

Risk level

110

-0.68%USD 14.50

Waystar Holding Corp

Waystar Holding Corp Valor: 130358792

Annual Return

-50%0%+50%

Risk level

110

-2.79%USD 25.07

Logos provided by Clearbit

Denali Therapeutics Inc

DNLI

ISIN null / Valor 39149539

Denali Therapeutics Inc UMushroom community rating:

John Noyb

Denali Therapeutics Inc
UMushroom community rating: